As the market becomes more dynamic and prices fall across the GLP-1 landscape, more eligible patients are now able to find the treatment that works best for their lifestyle and budget
Erdogdu O, Nathanson D, Sjholm A, Nystrm T, Zhang Q: Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
Reduced benefits: Using doses that are too low may limit benefit, while stopping or adjusting treatment without follow-up can interfere with long-term metabolic or health goals
Another factor is progress speed
It also supports metabolic health by improving how your body handles fat storage and insulin sensitivity
Mounjaro (tirzepatide)popular for managing Type 2 diabetes and chronic weight losson the other hand posted its first monthly sales drop, from Rs 135 crore in February to Rs 114 crore in March